These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33968158)

  • 1. PAR2 Promoter Hypomethylation Regulates PAR2 Gene Expression and Promotes Lung Adenocarcinoma Cell Progression.
    Wu K; Xu L; Cheng L
    Comput Math Methods Med; 2021; 2021():5542485. PubMed ID: 33968158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
    Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
    Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1.
    Lai Q; Wan Y; Zhang Y; Huang Y; Tang Q; Chen M; Li Q; Ma K; Xiao P; Luo C; Zhuang X
    Mol Carcinog; 2024 Jul; 63(7):1260-1274. PubMed ID: 38607240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANLN Regulated by miR-30a-5p Mediates Malignant Progression of Lung Adenocarcinoma.
    Deng F; Xu Z; Zhou J; Zhang R; Gong X
    Comput Math Methods Med; 2021; 2021():9549287. PubMed ID: 34777569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
    Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
    Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma.
    Jin X; Zhou H; Song J; Cui H; Luo Y; Jiang H
    Comput Math Methods Med; 2021; 2021():9971353. PubMed ID: 34257701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of CLEC14A is associated with its expression and lung adenocarcinoma progression.
    Su C; Shi K; Cheng X; Han Y; Li Y; Yu D; Liu Z
    J Cell Physiol; 2019 Mar; 234(3):2954-2962. PubMed ID: 30191970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.
    Chen S; Zhu X; Zheng J; Xu T; Xu Y; Chen F
    Comput Math Methods Med; 2021; 2021():6241469. PubMed ID: 34306175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Methylation-Mediated Low Expression of CFTR Stimulates the Progression of Lung Adenocarcinoma.
    Wang Y; Tang L; Yang L; Lv P; Mai S; Xu L; Wang Z
    Biochem Genet; 2022 Apr; 60(2):807-821. PubMed ID: 34498165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
    Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1QTNF6 Targeted by MiR-184 Regulates the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.
    Rao X; Lu Y
    Mol Biotechnol; 2022 Nov; 64(11):1279-1287. PubMed ID: 35578071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration.
    Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X
    Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma.
    Wang W; Li S
    Recent Pat Anticancer Drug Discov; 2024; 19(5):652-665. PubMed ID: 37877146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma.
    Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M
    Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13.
    Wu X; Wang W; Wu G; Peng C; Liu J
    Comput Math Methods Med; 2021; 2021():7074343. PubMed ID: 34335864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.